0000946644
2025-01-01
2025-12-31
0000946644
2024-01-01
2024-12-31
0000946644
2023-01-01
2023-12-31
0000946644
AIM:EquityAwardsValueInCompensationTableMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:EquityAwardsAdjustmentsMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:EquityAwardsValueInCompensationTableMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:EquityAwardsAdjustmentsMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:EquityAwardsValueInCompensationTableMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:EquityAwardsAdjustmentsMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:PeoMember
2025-01-01
2025-12-31
0000946644
AIM:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:PeoMember
2024-01-01
2024-12-31
0000946644
AIM:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:PeoMember
2023-01-01
2023-12-31
0000946644
AIM:LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:AverageEquityAwardAdjustmentsMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:AverageEquityAwardAdjustmentsMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:AverageEquityAwardAdjustmentsMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:NonPeoNeoMember
2025-01-01
2025-12-31
0000946644
AIM:AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:NonPeoNeoMember
2024-01-01
2024-12-31
0000946644
AIM:AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
0000946644
AIM:AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember
ecd:NonPeoNeoMember
2023-01-01
2023-12-31
iso4217:USD
false
0000946644
DEF 14A
AIM ImmunoTech Inc.
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we grant stock options to our employees, including our named executive officers. Historically, we have granted new-hire
equity awards, which often include stock options, on or soon after a new hire’s employment start date and annual awards, which
often include stock options, generally in the first quarter of each fiscal year, which annual grants are typically approved at a regularly
scheduled meeting of the Compensation Committee occurring in such quarter. Also, non-employee directors receive automatic grants of initial
and annual stock option awards, at the time of a director’s initial appointment or election to the Board and at the time of each
annual meeting of our stockholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under
the heading, “Director Compensation” below. We do not otherwise maintain any written policies on the timing of awards of
stock options, stock appreciation rights, or similar instruments with option-like features.</span>We
do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardTmgPredtrmndFlag_dbF_c20250101__20251231_z1e8nr95wsU4">not</span> grant equity awards in anticipation of the release of material nonpublic information, or MNPI, and we do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_zyv1Fo08H0Jb">not</span> time the release
of MNPI based on equity award grant dates or for the purposes of affecting the value of executive compensation. During 2025, we did not
grant any stock options to our named executive officers. We have no information to disclose pursuant to Item 402(x)(2) of Regulation
S-K.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--MnpiDiscTimedForCompValFlag_dbF_c20250101__20251231_zXuKSrQyc15b">not</span> have a policy that prohibits employees (including officers) and directors or any of their designees, from purchasing financial
instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engaging in transactions,
that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company’s equity securities granted
to the employee or director by the Company as part of the compensation of the employee or director or otherwise held, directly or indirectly,
by the employee or director.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
false
false
false
<table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zjT791flE9vj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary
Compensation Table Total for PEO <span>(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation
Actually Paid to PEO <sup>(1)</sup> (2) (3)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zOpGohD96Zoi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average
Summary Compensation Table Total for Non-PEO NEOs <span id="xdx_F57_z6gUqklgjDp">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Compensation Actually Paid to Non-PEO NEOs (1) (2)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_482_eecd--TotalShareholderRtnAmt_pp2d_zSBJiyrdBt" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value
of Initial Fixed $100 Investment Based On Total Shareholder Return <span id="xdx_F5F_zl5EdStWypDe">(4)</span></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_48C_eus-gaap--NetIncomeLoss_zpCfqodIttma" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net
Income (Loss) <span id="xdx_F5A_z0W4YCeMXssc">(5)</span></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr id="xdx_410_20250101__20251231_ztz9pGUbafM3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 16%; text-align: center">2025</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--PeoTotalCompAmt_c20250101__20251231_fKDEp_zJtZOqMhyvxj" style="width: 10%; text-align: right">640,243</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20250101__20251231_fKDEpKDIpKDMp_zlJIxZjMmJXd" style="width: 10%; text-align: right" title="PEO Actually Paid Compensation Amount">640,243</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">246,039</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20250101__20251231_fKDEpKDIp_zEo39UkfjGX4" style="width: 10%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">246,039</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">3.64</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(13,958,000</td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_419_20240101__20241231_zgYi8WrQfRJ5" style="vertical-align: bottom; background-color: White">
<td style="text-align: center">2024</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_986_eecd--PeoTotalCompAmt_c20240101__20241231_fKDEp_z7PsI2eiN3O7" style="text-align: right">1,089,725</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_fKDEpKDIpKDMp_zKc4OofpRl7h" style="text-align: right" title="PEO Actually Paid Compensation Amount">1,067,109</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">285,935</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDEpKDIp_z27ZCM1tWeE1" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">282,166</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">63.87</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(17,320,000</td><td style="text-align: left">)</td></tr>
<tr id="xdx_418_20230101__20231231_z14vgeIe9y2k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2023</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_z32LEnqPgDuh" style="text-align: right">1,431,301</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDEpKDIpKDMp_z31HKa5aSl9g" style="text-align: right" title="PEO Actually Paid Compensation Amount">1,458,539</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">369,860</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDEpKDIp_z6Ha1ebsqDOj" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">375,160</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">141.94</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(28,962,000</td><td style="text-align: left">)</td></tr>
</table>
640243
640243
246039
246039
3.64
-13958000
1089725
1067109
285935
282166
63.87
-17320000
1431301
1458539
369860
375160
141.94
-28962000
<p id="xdx_893_eecd--NamedExecutiveOfficersFnTextBlock_dU_zbXiQSxh4ig5" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal executive
officer (“<b><i>PEO</i></b>”) and the non-PEO NEOs for each year are as follows: <span id="xdx_90E_eecd--PeoName_c20250101__20251231_zjKNOR89f9zb"><span id="xdx_900_eecd--PeoName_c20240101__20241231_zvaabtgxmfF2"><span id="xdx_903_eecd--PeoName_c20230101__20231231_zH0MnDjam1Md">Thomas K. Equels</span></span></span>, PEO; Robert Dickey
and Peter Rodino, NEOs.</span></td></tr>
</table>
Thomas K. Equels
Thomas K. Equels
Thomas K. Equels
<p id="xdx_893_eecd--AdjToPeoCompFnTextBlock_dU_z0B9Fvd9sUT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for PEO</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Less: Summary Compensation Table Reported Value of Equity Awards(a)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Plus: Equity Award Adjustments(b)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equals: Compensation Actually Paid to PEO</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 20%; text-align: center">2025</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--PeoTotalCompAmt_c20250101__20251231_zec5Px2iEzgj" style="width: 16%; text-align: right">640,243</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--EquityAwardsValueInCompensationTableMember__ecd--IndividualAxis__ecd--PeoMember_fKGEp_zmiczEcswbEi" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0058">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_fKGIp_zfd3ujMYHhj" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0059">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20250101__20251231_z97fEMlapUQ3" style="width: 16%; text-align: right">640,243</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: center">2024</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98F_eecd--PeoTotalCompAmt_c20240101__20241231_zVKv5Y0gErG1" style="text-align: right">1,089,725</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--EquityAwardsValueInCompensationTableMember__ecd--IndividualAxis__ecd--PeoMember_fKGEp_zbc3aEX7o5Sl" style="text-align: right">(200,000</td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_fKGIp_zLDvWe7mTnVg" style="text-align: right">177,384</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98F_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zEWLHIiWWgCd" style="text-align: right">1,067,109</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2023</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231_zTqlU8XOZZva" style="text-align: right">1,431,301</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--EquityAwardsValueInCompensationTableMember__ecd--IndividualAxis__ecd--PeoMember_fKGEp_ze8zENAp2mzd" style="text-align: right">(128,112</td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_fKGIp_zDTVC4bKEOd6" style="text-align: right">155,350</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_z59dc1OfqASa" style="text-align: right">1,458,539</td><td style="text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F04_zi9ykAgCEFR5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zcQT9rmzL0z7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the aggregate grant-date fair value of equity awards as reported in the “Option Awards” columns in the “Summary Compensation
Table” for the applicable year.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F04_zV1rrZzq7Mpg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zHHfqLatJ4Y3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The equity award adjustments
for each applicable year were as set forth in the table below. The valuation assumptions used to calculate fair values did not materially
differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as
follows:</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year End Fair Value of Outstanding and Unvested Equity Awards Granted in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Vesting Date Fair Value of Equity Awards Granted in the Covered Year that Vested in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year (From Prior Year End to Vesting Date)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value at the End of the Prior Year of Equity Awards that Failed to Vest in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Dividend Equivalents Accrued or other Earnings Paid on Stock Awards not Otherwise Reflected in Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Equity Award Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2025</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zMGf34frontk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0071">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--PeoMember_zB2YWdra02Ve" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0072">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td id="xdx_982_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zIj20yMhHagd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0073">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--PeoMember_z1bLXzLAU1B5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0074">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zvpifx82T6wj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0075">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--PeoMember_z4J1RSJfKSr1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0076">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_zTfoJO1I8RFh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 12%; text-align: center">2024</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zLgBM8g4KeAd" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0078">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--PeoMember_zpaH5ncwXCBa" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0079">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zyrNrovk6lqf" style="width: 10%; text-align: right">200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--PeoMember_zyFdB4uU8cm4" style="width: 10%; text-align: right">(22,616</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zDgaApXjM1C3" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--PeoMember_zI34VthMBoz" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_zdUhIo05EM1c" style="width: 8%; text-align: right">177,384</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2023</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zp7g8MOIQnR1" style="text-align: right">108,555</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--PeoMember_zoe72HsyQxn4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zuMNYW0tpSka" style="text-align: right">9,869</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--PeoMember_zY5IABZvHWyf" style="text-align: right">36,926</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--PeoMember_zSKhqj4hlDM1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0089">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--PeoMember_zAymqaG3MhXb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0090">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--EquityAwardsAdjustmentsMember__ecd--IndividualAxis__ecd--PeoMember_zglELinm44ue" style="text-align: right">155,350</td><td style="text-align: left"> </td></tr>
</table>
640243
640243
1089725
-200000
177384
1067109
1431301
-128112
155350
1458539
200000
-22616
177384
108555
9869
36926
155350
<p id="xdx_89B_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zqofFI975wfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The dollar amounts
reported in the “Average Compensation Actually Paid to Non-PEO NEOs” column represent the average amount of
“compensation actually paid” to the NEOs as a group (excluding the PEO), as computed in accordance with SEC rules. The
dollar amounts do not reflect the actual amount of compensation earned by or paid to the NEOs (excluding the PEO) during the
applicable year. In accordance with the SEC rules, the following adjustments were made to average total compensation for the NEOs as
a group (excluding the PEO) or each year to determine the compensation actually paid:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Reported Summary Compensation Table Total for Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Less: Summary Compensation Table Average Reported Value of Equity Awards</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Plus: Average Equity Award Adjustments(x)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equals: Average Compensation Actually Paid to Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 20%; text-align: center">2025</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20250101__20251231_zytgWN4zaHja" style="width: 16%; text-align: right">246,039</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zuF9ZV3cM1gb" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0095">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_fKHgp_zlDI2l0nXLnd" style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0096">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20250101__20251231_zo71exDkZEba" style="width: 16%; text-align: right">246,039</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: center">2024</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98D_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_zhAY2X7hhJEb" style="text-align: right">285,935</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zwrDeNUSp5f3" style="text-align: right">(25,000</td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_fKHgp_zEtSTLs3QjQl" style="text-align: right">21,231</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_ztvpKmJCwd76" style="text-align: right">282,166</td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2023</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zzGY3BNgiuef" style="text-align: right">369,860</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--LessSummaryCompensationTableAverageReportedValueOfEquityAwardsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOhs3OXCvj6" style="text-align: right">(21,352</td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_fKHgp_zDMss4FEvWM9" style="text-align: right">26,652</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zbFv0q93sPAh" style="text-align: right">375,160</td><td style="text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F06_zGU6SluX7AEd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zTyuuZHi0nsb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts deducted or
added in calculating the <b>total average equity award adjustments</b> are as follows (figures in columns other than “Total
Average Equity Award Adjustments” are rounded to the nearest dollar):</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Year End Fair Value of Outstanding and Unvested Equity Awards Granted in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Vesting Date Fair Value of Equity Awards Granted in the Covered Year that Vested in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year (From Prior Year End to Vesting Date)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value at the End of the Prior Year of Equity Awards that Failed to Vest in the Covered Year</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Value of Dividend Equivalents Accrued or other Earnings Paid on Stock Awards not Otherwise Reflected in Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Average Equity Award Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2025</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zlwuPIo2t0Rc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0107">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zXd9FtodSYV5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_986_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zNIa5Jtt9SG1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zy7hd20gpTl1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0110">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z39M51ynhxOd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zjcFu8Yblfyc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zLqGeP2ScSE3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0113">-</span></td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 12%; text-align: center">2024</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_ztbs0mSdnvPg" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zFHpbysFhuP2" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z4ANH5Fudhxg" style="width: 10%; text-align: right">25,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zolXZFRJ6ukd" style="width: 10%; text-align: right">(3,769</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z5h3esbB4Ov9" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zDbDVbhEIEHb" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zKnNQLEXsIO5" style="width: 8%; text-align: right">21,231</td><td style="width: 1%; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: center">2023</td><td> </td>
<td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z2zRQDM1Tbmi" style="text-align: right">18,092</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z7hvuDXd0qee" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zUyKnn7oM5t5" style="text-align: right">1,645</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDateMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zvlibLr1i125" style="text-align: right">6,915</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYearMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_zkpmzOuKQ9v2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0125">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_z7NVwcUDXfEl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0126">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageEquityAwardAdjustmentsMember__ecd--IndividualAxis__ecd--NonPeoNeoMember_ze52fczwRdre" style="text-align: right">26,652</td><td style="text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating the “<b>compensation actually paid</b>” amounts reflected in these columns, the fair value or change in fair
value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718.
The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant.</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company total shareholder
return (“<b><i>TSR</i></b>”) represents the cumulative investment return of an initial fixed $100 investment in our common
stock during the period commencing on December 31, 2021 and ending on the last day of the covered fiscal year, assuming reinvestment
of all dividends. The Company TSR reflected in the table above may not be indicative of future performance.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the amount of
net income (loss) reflected in the Company’s audited GAAP financial statements for each applicable fiscal year.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
objective of the “Pay Versus Performance Table” is to illustrate how performance-based features in our executive compensation
program operate to index pay to performance. As further explained below, we believe that the table reflects an alignment of compensation
actually paid with the decline in the Company’s performance.</span></p>
246039
246039
285935
-25000
21231
282166
369860
-21352
26652
375160
25000
-3769
21231
18092
1645
6915
26652
<p id="xdx_89D_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zct4kuTvtsW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Actually Paid versus Company Total Shareholder Return</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
outlined in the table, increases in the compensation actually paid values for our PEO and non-PEO NEOs from 2023 to 2025 are directionally
aligned with the changes in our total shareholder return over this same period. The decrease in compensation from 2023 to 2025 is primarily
a result of the PEO and an NEO not receiving a bonus in 2024 or 2025 when compared to 2023. In 2025 and 2024, the PEO and non-PEO NEOs
agreed to voluntarily forego the cash bonuses for 2025 and 2024 for which they are entitled to pursuant to their employment agreements
to conserve cash for the Company, which primarily resulted in a reduction in their compensation actually paid. Additionally, the PEO
and non-PEO NEO did not receive stock awards for 2025. These reductions were offset by the change in type of salary that they received.
The PEO and non-PEO NEO reduced their cash compensation within their salary in 2024 for an annual period and receiving common stock the
for the total amount of the reduction, which was valued equal to 100% of the closing price of our common stock on the trading date immediately
preceding the date of issuance of the shares in accordance with the compensation arrangements. As a portion of their annual salary for
the 2024-2025 period was received in common stock in 2024. Due to this net change the compensation actually paid decreased and was aligned
with the total shareholder return decrease. Our compensation programs are structured based on short-term and long-term compensation for
the NEOs. As we have been primarily focused on conserving cash in the short-term, these compensation arrangements to reduce cash compensation
met our short-term needs. Long-term compensation is provided by non-qualified yearly stock options within yearly vesting. The ultimate
value of these equity awards, and the resulting impact on compensation actually paid, aligns with our total shareholder return performance.
In 2025, the PEO and non-PEO NEOs were not awarded their yearly stock options. While the overall total shareholder return performance
has declined, compensation actually paid decreased as a result of the structuring of the compensation arrangements.</span></p>
<p id="xdx_899_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z5Al5bkL5jNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Actually Paid versus Company Net Income</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
outlined in the table, decreases in the compensation actually paid values for our PEO and non-PEO NEOs occurred from 2023 to 2025, while
the net loss decreased for the same period. The decrease in compensation actually paid from 2023 to 2025 is primarily the result of the
structuring of the compensation arrangements for the PEO and non-PEO NEOs. In 2025 and 2024, the PEO and non-PEO NEOs agreed to voluntarily
forego the cash bonuses for 2025 and 2024 for which they are entitled to pursuant to their employment agreements to conserve cash for
the Company, which primarily resulted in a reduction in their compensation actually paid, which would not align with the decrease in
the net loss. As we have been primarily focused on the clinical and regulatory development of Ampligen and, accordingly, we have not
historically used net income (loss) as a performance measurement in our executive compensation. As a pre-commercial stage company, our
performance is attributable to the successful execution of our regulatory, clinical, research and commercial goals. Therefore, while
the Board monitors our net income (loss), we do not currently believe there is a meaningful relationship between our net loss and compensation
actually paid to our NEOs during the periods presented.</span></p>